Insilico design of an allosteric modulator targeting the protein–protein interaction site of 3 Phosphoinositide dependent Kinase-1: design, synthesis and biological activity-Reference-Cited by-同舟云学术

Insilico design of an allosteric modulator targeting the protein–protein interaction site of 3 Phosphoinositide dependent Kinase-1: design, synthesis and biological activity

Published:2023-09-25 Issue:1 Volume:11 Page:
ISSN:2193-9616
Container-title:In Silico Pharmacology
language:en
Short-container-title:In Silico Pharmacol.

Author:

Kailasam Natesan Vennila,Balaraman Selvakumar,KuppannaGounder Pitchaimuthu Elango

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40203-023-00160-6.pdf

Reference33 articles.

1. Anant A, Ali A, Ali A, Gupta GD, Asati V (2021) A Computational approach to discover potential quinazoline derivatives against CDK4/6 kinase. J Mol Struct 1245:131079

2. Arencibia JM, Fröhner W, Krupa M, Pastor-Flores D, Merker P, Oellerich T et al (2017) An allosteric inhibitor scaffold targeting the PIF-pocket of atypical protein kinase C isoforms. ACS Chem Biol 12(2):564–573

3. Asati V, Agarwal S, Mishra M, Das R, Kashaw SK (2020) Structural prediction of novel pyrazolo-pyrimidine derivatives against PIM-1 kinase: In-silico drug design studies. J Mol Struct 1217:128375

4. Bai LY, Chiu CF, Kapuriya NP, Shieh TM, Tsai YC, Wu CY et al (2015) BX795, a TBK1 inhibitor, exhibits antitumor activity in human oral squamous cell carcinoma through apoptosis induction and mitotic phase arrest. Eur J Pharmacol [internet] 769:287–296

5. Beekman AM, Cominetti MMD, Walpole SJ, Prabhu S, O’Connell MA, Angulo J et al (2019) Identification of selective protein-protein interaction inhibitors using efficient: in silico peptide-directed ligand design. Chem Sci 10(16):4502–4508